CBA Research
CompanyUnited States
CBA Research develops one asset, in phase 1 (CBT-1 in sarcoma). Mostly small molecule acting on ABCB1; based in the United States.
- 1
- Asset
- Furthest
- Phase 1
- 1
- Trial
- 0
- Signals
Pipeline
1Multidrug resistance modulator / P-glycoprotein inhibitor
Phase 1, Small molecule, ABCB1, sarcoma
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials1
- Similar companies6
Updated 7 Oct 2026 · 4 sources